[Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?]
- PMID: 12765124
[Is use of nitric oxide (NO) synthase inhibitors justified for therapy of septic shock?]
Abstract
NO mediates many systemic reactions in humans and animals. It is produced by constitutive synthases (cNOS) and one inducible by cytokines and endotoxines (iNOS). We summarize, on the base of experimental and clinical data, the pathophysiological role of NO in septic shock as well as the effects of pharmacological application of NOS inhibitors. The analysed data show, that the contribution of NO to the pathomechanism of septic shock is rather heterogenous, therefore the clinical therapeutical application of selective iNOS inhibitors is impossible without adequate new monitoring tools.
Similar articles
-
[Nitric oxide--an important mediator in sepsis?].Tidsskr Nor Laegeforen. 1999 Nov 10;119(27):4061-5. Tidsskr Nor Laegeforen. 1999. PMID: 10613098 Review. Norwegian.
-
Nitric oxide in sepsis-syndrome: potential treatment of septic shock by nitric oxide synthase antagonists.Kidney Int Suppl. 1998 Feb;64:S27-30. Kidney Int Suppl. 1998. PMID: 9475485 Review.
-
Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock.Thromb Haemost. 2006 Apr;95(4):720-7. Thromb Haemost. 2006. PMID: 16601845
-
Involvement and dual effects of nitric oxide in septic shock.Inflamm Res. 1998 Apr;47(4):152-66. doi: 10.1007/s000110050309. Inflamm Res. 1998. PMID: 9628258 Review.
-
Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.Toxicology. 2007 Oct 8;239(3):186-94. doi: 10.1016/j.tox.2007.07.006. Epub 2007 Jul 13. Toxicology. 2007. PMID: 17719164